
Historically, there are many hard-to-treat mutations of non-small cell lung cancer.
Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.
Historically, there are many hard-to-treat mutations of non-small cell lung cancer.
President (2022 to 2023) of the Hematology Oncology Pharmacists Association (HOPA) highlights the many ways that hematology/oncology pharmacists can collaborate with care teams to improve access to care at HOPA Annual Conference 2023 in Phoenix, Arizona from March 29 to April 1.
Follow Pharmacy Times®’ live coverage of the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference in Phoenix, Arizona from March 29 to April 1, 2023.
Dobbs v. Jackson muddied the waters for pharmacists in strict abortion states, who must make decisions despite misaligned state and federal laws.
Expert discusses how patients who participate in Ramadan, a month of fasting in Islam, can stay safe while doing it, and offers insight into how patients can work with pharmacists to adapt to their medication needs.
The pandemic was eye-opening for many pharmacists, and one expert reflects on recognizing the importance of the pharmacy technician and accessible healthcare.
An expert suggests that education and agency are significant barriers to care in marginalized communities, which she discusses live with Pharmacy Times at the American Pharmacists Association (APhA) Meeting & Exposition in Phoenix, Arizona from March 24 to 27.
Expert weighs the benefits and pitfalls of social media, the importance of quality information from credible journal sources, and why information that sparks an emotional response can be more influential than evidence-based facts.
Pharmacy Times is covering the American Pharmacists Association (APhA) Annual Meeting & Exposition in Phoenix, Arizona from March 24 to 27, 2023.
Children who died from fatal poisoning were often at home and in the presence of an adult.
3D biofabrication models reflect increasing global awareness of the ethics of preclinical studies and an increased need for determining therapeutic efficacy differences.
The COVID-19 pandemic marginally affected the negative mental health of women more than men, according to a new study.
Atea’s drug candidate is considered safe and effective against the viruses that cause COVID-19 and hepatitis C, according to new data presented at ICAR 2023.
Emotional support greatly improved symptoms of psychological distress from the pandemic among pregnant women.
Most patients used nonproprietary drugs, which may contribute to the reduction of out-of-pocket costs for the treatment of invasive breast cancer.
Niraparib with abiraterone acetate could be the first dual-action tablet for patients with metastatic castration-resistant prostate cancer and BRCA mutations.
Clostridioides difficile infection can have a significant impact on feelings of depression and anxiety, while worsening quality of life.
The risk of long COVID-19 was no worse for patients who had Omicron after the wild-type virus than those just diagnosed with the wild-type.
Perceived stress and cognitive performance are independently associated. Stress can also increase the risk of worsening cognition.
Patients with diabetes who followed a plant-based, low-carbohydrate diet and participated in healthy lifestyle habits experienced the most health benefits.
Molecular complexes can serve as a D-glucose chemical sensor with chiral selectivity and sensitivity to improve diabetes testing.
Emily Graham, PharmD, MS, BCOP, an Oncology Clinical Pharmacy Specialist at Allegheny Health Network in Pittsburg, Pennsylvania, discusses the potential outcomes of mirvetuximab for patients with platinum-resistant ovarian cancer.
Median overall survival was also 2 months less for patients with extensive-stage small cell lung cancer who were ineligible for clinical trials.
Frequent aspirin use associated with a 13% lower risk of nonmucinous ovarian cancer, which was consistent with findings from previous studies.
On April 2, 2023, the FDA will announce the approval status of Roche’s supplemental Biologics License Application for polatuzumab in the treatment of diffuse large B-cell lymphoma.
Zavegepant is the only calcitonin gene-related peptide receptor antagonist nasal spray indicated for acute treatment of migraine in adults and can provide pain relief in 15 minutes.
John E. Clark, PharmD, MS, FASHP, FFSHP, Director, Diversity, Equity, and Inclusion at the Taneja College of Pharmacy, University of South Florida, discusses the importance of addressing social determinants of health to improve patient outcomes.
Ventana PD-L1 (SP263) Assay can increase access to cemiplimab and improve patient outcomes in non-small cell lung cancer.
Nightlife transmission of COVID-19 affected a larger number of younger individuals but caused fewer household outbreaks in 2020.
Newly modified FreeStyle Libre 2 and FreeStyle Libre 3 sensors can be worn by children aged 2 years and older with diabetes.